Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein

(1) Background: As the COVID-19 pandemic enters its fourth year, it continues to cause significant morbidity and mortality worldwide. Although various vaccines have been approved and the use of homologous or heterologous boost doses is widely promoted, the impact of vaccine antigen basis, forms, dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dandan, Zhao, Heng, Liao, Yun, Jiang, Guorun, Cui, Pingfang, Zhang, Ying, Yu, Li, Fan, Shengtao, Li, Hangwen, Li, Qihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220924/
https://www.ncbi.nlm.nih.gov/pubmed/37243067
http://dx.doi.org/10.3390/vaccines11050963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220924/
https://www.ncbi.nlm.nih.gov/pubmed/37243067
http://dx.doi.org/10.3390/vaccines11050963

Ejemplares similares